These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21422053)

  • 21. APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis.
    Portaccio E; Goretti B; Zipoli V; Nacmias B; Stromillo ML; Bartolozzi ML; Siracusa G; Guidi L; Federico A; Sorbi S; De Stefano N; Amato MP
    Mult Scler; 2009 Dec; 15(12):1489-94. PubMed ID: 19965518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein E epsilon4 and change in cognitive functioning in community-dwelling older adults.
    Swan GE; Lessov-Schlaggar CN; Carmelli D; Schellenberg GD; La Rue A
    J Geriatr Psychiatry Neurol; 2005 Dec; 18(4):196-201. PubMed ID: 16306239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein E epsilon4, Alzheimer's disease, and cognitive performance in elderly Mexican Mestizos.
    Villalpando-Berumen JM; Mejia-Arango S; Aguilar-Salinas CA; Ordonez-Sanchez ML; Gutierrez-Robledo LM
    J Am Geriatr Soc; 2008 Apr; 56(4):677-82. PubMed ID: 18205760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ApoE genotype and cognition after subarachnoid haemorrhage: a longitudinal study.
    Louko AM; Vilkki J; Niskakangas T
    Acta Neurol Scand; 2006 Nov; 114(5):315-9. PubMed ID: 17022778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropsychological measures in normal individuals that predict subsequent cognitive decline.
    Blacker D; Lee H; Muzikansky A; Martin EC; Tanzi R; McArdle JJ; Moss M; Albert M
    Arch Neurol; 2007 Jun; 64(6):862-71. PubMed ID: 17562935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Most rapid cognitive decline in APOE epsilon4 negative Alzheimer's disease with early onset.
    van der Vlies AE; Koedam EL; Pijnenburg YA; Twisk JW; Scheltens P; van der Flier WM
    Psychol Med; 2009 Nov; 39(11):1907-11. PubMed ID: 19335933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. APOE genotype modulates the effect of serum calcium levels on cognitive function in old age.
    van Vliet P; Oleksik AM; Mooijaart SP; de Craen AJ; Westendorp RG
    Neurology; 2009 Mar; 72(9):821-8. PubMed ID: 19255409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.
    McGuinness B; Carson R; Barrett SL; Craig D; Passmore AP
    Neurosci Lett; 2010 Oct; 483(1):62-6. PubMed ID: 20678545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.
    Martins CA; Oulhaj A; de Jager CA; Williams JH
    Neurology; 2005 Dec; 65(12):1888-93. PubMed ID: 16380608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive impairment in Alzheimer's disease is modified by APOE genotype.
    van der Vlies AE; Pijnenburg YA; Koene T; Klein M; Kok A; Scheltens P; van der Flier WM
    Dement Geriatr Cogn Disord; 2007; 24(2):98-103. PubMed ID: 17596691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
    Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
    Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medial temporal lobe dysfunction during encoding and retrieval of episodic memory in non-demented APOE epsilon4 carriers.
    Kukolja J; Thiel CM; Eggermann T; Zerres K; Fink GR
    Neuroscience; 2010 Jun; 168(2):487-97. PubMed ID: 20350587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between memory complaints, perceived quality of life and mental health in apolipoprotein Eepsilon4 carriers and non-carriers.
    Sohrabi HR; Bates KA; Rodrigues M; Taddei K; Martins G; Laws SM; Lautenschlager NT; Dhaliwal SS; Foster JK; Martins RN
    J Alzheimers Dis; 2009; 17(1):69-79. PubMed ID: 19494432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between anticholinergic drugs and apolipoprotein E epsilon4 allele and poorer cognitive function in older cardiovascular patients: a cross-sectional study.
    Uusvaara J; Pitkala KH; Tienari PJ; Kautiainen H; Tilvis RS; Strandberg TE
    J Am Geriatr Soc; 2009 Mar; 57(3):427-31. PubMed ID: 19278396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinal magnetic resonance imaging vascular changes, apolipoprotein E genotype, and development of dementia in the neurocognitive outcomes of depression in the elderly study.
    Steffens DC; Potter GG; McQuoid DR; MacFall JR; Payne ME; Burke JR; Plassman BL; Welsh-Bohmer KA
    Am J Geriatr Psychiatry; 2007 Oct; 15(10):839-49. PubMed ID: 17623814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Homocysteine and cognitive performance: modification by the ApoE genotype.
    Elias MF; Robbins MA; Budge MM; Elias PK; Dore GA; Brennan SL; Johnston C; Nagy Z
    Neurosci Lett; 2008 Jan; 430(1):64-9. PubMed ID: 18023533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of extracerebral cholesterol homeostasis and ApoE e4 in cognitive decline.
    van den Kommer TN; Dik MG; Comijs HC; Lütjohann D; Lips P; Jonker C; Deeg DJ
    Neurobiol Aging; 2012 Mar; 33(3):622.e17-28. PubMed ID: 21482441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adverse Childhood and Recent Negative Life Events: Contrasting Associations With Cognitive Decline in Older Persons.
    Korten NC; Penninx BW; Pot AM; Deeg DJ; Comijs HC
    J Geriatr Psychiatry Neurol; 2014 Jun; 27(2):128-38. PubMed ID: 24578461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Albumin, apolipoprotein E-epsilon4 and cognitive decline in community-dwelling Chinese older adults.
    Ng TP; Niti M; Feng L; Kua EH; Yap KB
    J Am Geriatr Soc; 2009 Jan; 57(1):101-6. PubMed ID: 19054180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of cardiovascular and metabolic disease on cognitive test performance and cognitive change in older adults.
    Köhler M; Kliegel M; Kaduszkiewicz H; Bachmann C; Wiese B; Bickel H; Mösch E; Weyerer S; Werle J; Fuchs A; Pentzek M; Leicht H; König HH; Luppa M; Riedel-Heller S; Jessen F; Maier W; Scherer M; Wagner M;
    J Am Geriatr Soc; 2012 Jul; 60(7):1286-91. PubMed ID: 22703453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.